Tachycardia, Supraventricular Clinical Trial
Official title:
Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias: a Randomized Controlled Trial
The aim of this single-center prospective randomized controlled trial is to assess the superiority of contact-force-(CF)-sensing-based approach compared to conventional (non-CF-sensing) approach in the catheter ablation of PSVTs, and to investigate the safety of open-irrigated, contact-force-sensing ablation catheters (used in a "non-irrigated" mode) in these procedures.
Rationale:
Multiple studies have demonstrated the importance of adequate catheter-tissue contact in the
creation of effective lesions during radiofrequency catheter ablation. The development of
contact-force(CF)-sensing catheters have contributed significantly to improve clinical
outcomes in atrial fibrillation 3-18. However CF-sensing technology is not used in the
ablation of paroxysmal supraventricular tachycardia. Although PSVT ablation with the
conventional approach (non-irrigated, non-CF-sensing catheters) is considered a relatively
low-risk procedure with fairly high success rate (short-and long-term) 1,2,19, we hypothesize
that contact-force sensing can further improve the outcomes of these procedures. Based on the
results of studies on atrial fibrillation ablation (mentioned above) we believe that
CF-sensing could similarly improve such important parameters as radiofrequency (RF)
application number/time, total procedure time, and fluoroscopy time in cases of PSVT
ablations, as well. In addition CF-sensing could also further improve acute
success/recurrence rates of PSVT ablation, and might also be capable to further diminish
complication risk.
Primary Objective:
The primary objective of the present study is to demonstrate the superiority of
contact-force-sensing in the ablation of AVNRT and WPW-AVRT as assessed by the improvement in
the number and duration of radiofrequency applications compared with the conventional
ablation approach.
Secondary Objective:
Secondary objectives of the study are the followings:
- to demonstrate that contact-force-sensing catheters are superior in terms of total
procedure duration and fluoroscopy times in the case of AVNRT/WPW-AVRT ablation.
- to show that the use of contact-force sensing catheters is non-inferior to conventional
catheters (without contact-force-sensing) in terms of acute/long-term procedural success
and procedural safety (major/minor complication rate) of AVNRT/WPW-AVRT ablations.
Study population:
All patients above 18 years without structural heart disease being referred for
electrophysiological study and potential treatment with radiofrequency catheter ablation of
atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular reentrant
tachycardia (AVRT) with manifest (WPW syndrome) or concealed accessory pathways.
Intervention:
One group undergoes manual ablation using standard non-irrigated ablation catheters and the
other group undergoes manual ablation with an open-irrigated ablation catheter equipped with
CF- sensing (and utilized in a non-irrigated mode during ablation)
Main study parameters/endpoints:
The main study endpoint is the difference in RF application number during the procedures of
AVNRT/WPW-AVRT ablation; secondary endpoints are differences in RF application rate, acute
success rate, long-term recurrence rate (1 year) major/minor complication rate, and total
procedure/fluoroscopy time.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01223469 -
TOCCATA - Touch+™ for Catheter Ablation
|
N/A | |
Recruiting |
NCT01222156 -
Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping
|
Phase 1/Phase 2 | |
Completed |
NCT05357716 -
Preliminary Research Evaluation for Ambulatory Leadless Electrocardiogram Recorder Trial
|
||
Completed |
NCT03243604 -
cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study
|
||
Recruiting |
NCT03376438 -
Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia
|
||
Recruiting |
NCT05410860 -
Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
|
Phase 3 | |
Completed |
NCT02783898 -
The IPED (Investigation of Palpitations in the ED) Study
|
N/A | |
Recruiting |
NCT06077799 -
prehospItal maNagement oF paroxysmaL supraventrICular Tachycardia
|
||
Recruiting |
NCT04716270 -
Ablation of Supraventricular Arrhythmias With As Low As Reasonably Achievable X-Ray Exposure
|
||
Recruiting |
NCT05676398 -
Cardiac Arrhythmias at Extreme Altitude
|
||
Completed |
NCT00289289 -
Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT)
|
N/A | |
Completed |
NCT00005237 -
Epidemiology of Symptomatic Arrhythmias
|
N/A |